Literature DB >> 2004439

Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies.

K S Pettersson1, J R Söderholm.   

Abstract

We screened 11 monoclonal anti-lutropin (LH) antibodies for use in two-site immunometric combinations, with time-resolved fluorescence as the detection principle. Seven immunofluorometric assays (IFMA), six detecting only the intact hormone and one detecting both the intact hormone and free beta subunit, were compared with each other and with a conventional radioimmunoassay involving a polyclonal antiserum. Two monoclonal antibodies that exclusively reacted with intact LH showed restricted reactivity with LH in 25% of the samples tested. The LH of one individual was not detected at all by one of the antibodies. The existence of two distinct populations suggests the existence of a genetic variant of LH. A comparison of the results obtained by IFMAS with those by radioimmunoassay showed marked discrepancies in the low range, with IFMAS measuring much lower values. The excellent correlation between the various monoclonal IFMA strongly suggests that the discrepancies seen are caused by the insufficient sensitivity and matrix effects of the radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004439

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS.

Authors:  Juan C Castillo; Juan Garcia-Velasco; Peter Humaidan
Journal:  J Assist Reprod Genet       Date:  2012-01-12       Impact factor: 3.412

2.  European collaborative study of luteinizing hormone assay: 1. Epitope specificity of luteinizing hormone monoclonal antibodies and surface mapping of pituitary and urinary luteinizing hormone.

Authors:  S Costagliola; P Niccoli; M Florentino; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

Review 3.  Glycoprotein hormone isomorphism and assay discrepancy: the paradigm of luteinizing hormone (LH).

Authors:  S Costagliola; P Niccoli; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

4.  European collaborative study of LH assay: 3. relationship of immunological reactivity, biological activity and charge of human luteinizing hormone.

Authors:  P Niccoli; S Costagliola; M C Patricot; B Mallet; M Benahmed; P Carayon
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

5.  Undetectable luteinizing hormone levels using a monoclonal immunometric assay.

Authors:  F Barbé; H Legagneur; V Watrin; M Klein; Y Badonnel
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

6.  Patterns of LHbetacf among women in health and disease.

Authors:  Steven Birken; Ruth McChesney; Oksana Yershova; John Gaughan; Kim Pettersson; Geoff Rechenberg; Chung H Wu; George Taliadouros
Journal:  Mol Cell Endocrinol       Date:  2006-11-02       Impact factor: 4.102

7.  The common genetic variant of luteinizing hormone has a longer serum half-life than the wild type in heterozygous women.

Authors:  Leif Wide; Karin Eriksson; Patrick M Sluss; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2009-11-04       Impact factor: 5.958

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

9.  European collaborative study on luteinizing hormone assay: 2. Discrepancy among assay kits is related to variation both in standard curve calibration and epitope specificity of kit monoclonal antibodies.

Authors:  S Costagliola; P Niccoli; M Florentino; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

10.  A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology.

Authors:  Carlo Alviggi; Kim Pettersson; Salvatore Longobardi; Claus Yding Andersen; Alessandro Conforti; Pasquale De Rosa; Roberto Clarizia; Ida Strina; Antonio Mollo; Giuseppe De Placido; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2013-06-01       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.